KAZI HOSSAIN: Open Payments
NPI 1588920011 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$124 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $124
Food & beverage: $124
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Noven Therapeutics, LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
Products named: REXULTI, CAPLYTA, INGREZZA, Xelstrym, COBENFY, ARISTADA.
Industry payments across FL — which companies pay providers there.
